Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Study finds Omicron sublineage BA.2 is less pathogenic in rodent models than prior SARS-CoV-2 variants

Studying coagulopathy in COVID-19

Studying coagulopathy in COVID-19

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

Noncovalent protease inhibitors against SARS-CoV-2 and other coronaviruses

Vaccination reduces risk of long-COVID

Vaccination reduces risk of long-COVID

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

SARS-CoV-2 monitoring could be improved with use of bacterial metatranscriptomes in wastewater

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

No seroprevalence observed against SARS-CoV-2 in wild ruminants in Germany

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Study determines effectiveness of COVID-19 vaccination against Omicron variant in high-risk indoor settings

Will Omicron BA.2 become the next dominant variant?

Will Omicron BA.2 become the next dominant variant?

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Emergence of SARS-CoV-2 Omicron likely due to immune selective pressure

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

Altered microbiomes in SARS-CoV-2 infection pose threat of antibiotic resistance

The epidemiology of COVID-19 in Africa

The epidemiology of COVID-19 in Africa

A promising new vaccine for SARS-CoV-2 and influenza

A promising new vaccine for SARS-CoV-2 and influenza

Examining a case study of COVID-19 response and vaccine hesitancy in South Africa

Examining a case study of COVID-19 response and vaccine hesitancy in South Africa

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

Clinical severity of patients hospitalized with SARS-CoV-2 infection during the Omicron wave in South Africa

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Outcomes of SARS-Cov-2 infection in patients undergoing active anti-cancer treatment

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Protective immunity signatures provided by convalescent plasma for the development of COVID-19 antibody therapeutics

Study suggests history of childhood traumas may increase the risk of long COVID

Study suggests history of childhood traumas may increase the risk of long COVID

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

Rapid evidence summary on SARS-CoV-2 surface survival and efficacy of ozone machines against SARS-CoV-2

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

mRNA vaccines found to be highly effective against COVID-19 infections before the emergence of SARS-CoV-2 Delta variant

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

Severe COVID-19 outcomes in breakthrough infections in patients being treated with B cell depleting therapy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.